Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glucosamine sulfate + ginkgo biloba is a combination product consisting of the amino sugar glucosamine sulfate and a standardized extract from the leaves of the *Ginkgo biloba* tree. Primarily studied as a natural health product or dietary supplement, this combination is investigated for its therapeutic potential in managing osteoarthritis, particularly of the knee, and for its potential antifungal properties. Glucosamine sulfate serves as a biochemical precursor for glycosaminoglycans and proteoglycans, which are essential components of articular cartilage matrix. *Ginkgo biloba* extract contributes antioxidant, anti-inflammatory, and circulatory-enhancing effects, partially through the antagonism of platelet-activating factor (PAF) receptors. Clinical research, including trials organized by KGK Science Inc., has evaluated the efficacy of this combination in reducing joint pain as measured by the WOMAC index, suggesting it may offer superior clinical utility compared to glucosamine alone or in combination with chondroitin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glucosamine sulfate + ginkgo biloba.